Anti-Human ACVR2A & ACVR2B Recombinant Antibody
-
产品编号
YR1301
-
别名
科研级 Bimagrumab ( 比玛卢单抗 ), Anti-ACVR2A & ACVR2B Recombinant Antibody, Research Grade Bimagrumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Bimagrumab ( 比玛卢单抗 ), Anti-ACVR2A & ACVR2B Recombinant Antibody, Research Grade Bimagrumab |
| Catalog Number | YR1301 |
| Molecular Name | Bimagrumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Lambda |
| Formulation | PBS, pH7.5 |
| Background | Bimagrumab (BYM338) is a human monoclonal antibody developed by Novartis to treat pathological muscle loss and weakness. On August 20, 2013, it was announced that bimagrumab had received a breakthrough therapy designation for sporadic inclusion body myositis (sIBM) by the US Food and Drug Administration. |
| CAS Number | 1356922-05-8 |
| Application | FCM, IP, ELISA, Neut, FuncS, IF, ICC, MRI |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | ACVR2A & ACVR2B[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
